Effects of p38 Inhibitor AZD7624 in Corticosteroid Resistant Asthma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Prednisone
Related studies linked through entity extraction aliases.
Chidamide Plus R-CHOP in Elderly DLBCL
- Status
- UNKNOWN
- Phase
- PHASE2
Reduced Chemotherapy in Low Risk DLBCL
- Status
- UNKNOWN
- Phase
- PHASE4
Perioperative Oral Steroids for Chronic Rhinosinusitis Without Polyps (CRSsNP)
- Status
- COMPLETED
- Phase
- NA
A Study of Brentuximab Vedotin, Rituximab, and Dose Attenuated CHP in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Leflunomide for Maintenance of Remission in IgG4 Related Disease
- Status
- COMPLETED
- Phase
- PHASE4
Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)
- Status
- WITHDRAWN
- Phase
- PHASE2
Low-dose Chemotherapy Combine With Tyrosine Kinase Inhibitor to Treat ph+ Acute Lymphoblastic Leukemia Patients
- Status
- UNKNOWN
- Phase
- PHASE4
Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Sirolimus Associated With Tacrolimus at Low Doses in Elderly Kidney Transplant Patients
- Status
- COMPLETED
- Phase
- PHASE4
HD21 for Advanced Stages
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Modified MRCUKALLⅫ/ECOGE2993 Regimen for ALL
- Status
- UNKNOWN
- Phase
- PHASE2
Adjusted Steroids Therapy in Childerens With Idiopathic Nephrotic Syndrome
- Status
- UNKNOWN
- Phase
- PHASE4
Smart Start: A Phase II Study of Rituximab, Lenalidomide, and Ibrutinib
- Status
- COMPLETED
- Phase
- PHASE2
Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)
- Status
- TERMINATED
- Phase
- PHASE3
MabionCD20 Compared to MabThera in Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE3
Duvelisib With Rituximab vs R-CHOP in Subjects With Relapsed/Refractory Follicular Lymphoma (FRESCO)
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Atezolizumab in Combination With Either Obinutuzumab Plus Bendamustine or Obinutuzumab Plus (+) Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Participants With Follicular Lymphoma (FL) or Rituximab + CHOP in Participants With Diffuse Large B-Cell Lymphoma (DLBCL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2